NCT04588168 Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma Status RECRUITING Phase NA
NCT04581824 Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Status TERMINATED Phase PHASE2
NCT04575935 Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial Status RECRUITING Phase PHASE3
NCT04570423 A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy Status RECRUITING Phase PHASE2
NCT04562727 Microwave Ablation Combined With Chemotherapy for Colorectal Liver Metastases: a Multicenter Cohort Study Status NOT_YET_RECRUITING Phase NA
NCT04558684 Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer Status SUSPENDED Phase PHASE1/PHASE2
NCT04536467 Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients Status ENROLLING_BY_INVITATION Phase PHASE2
NCT04509635 Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis Status UNKNOWN Phase PHASE3
NCT04495387 Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy Status UNKNOWN Phase N/A
NCT04433169 All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck Status UNKNOWN Phase PHASE2
NCT04420130 A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis(SHR-1210-HLJ-009) Status WITHDRAWN Phase NA
NCT04384601 Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT04364048 Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT04341480 The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19 Status UNKNOWN Phase N/A
NCT04333927 Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer Status UNKNOWN Phase PHASE2
NCT04322890 Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation Status RECRUITING Phase PHASE2
NCT04319874 Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma Status UNKNOWN Phase PHASE2
NCT04319471 Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma Status UNKNOWN Phase PHASE2